Results 191 to 200 of about 2,285,787 (260)

Safety and Efficacy of CD19-Targeted Chimeric Antigen Receptor (CAR) T-cells Generated Using DNA Transposon Systems: A Meta-Analysis. [PDF]

Cureus
Rajput A, Sajjad SA, Kumar A, Singh K.
europepmc   +1 more source

Chimeric Antigen Receptor (CAR) T Cells Releasing Soluble SLAMF6 Isoform 2 Gain Superior Anti-Cancer Cell Functionality in an Auto-Stimulatory Fashion. [PDF]

Cells
Harrer DC, Schlierkamp-Voosen T, Barden M, Pan H, Xydia M, Herr W, Dörrie J, Schaft N, Abken H.   +8 more
europepmc   +1 more source

Interleukin-10 gives exhausted chimeric antigen receptor (CAR) T cells a second breath. [PDF]

Cancer Commun (Lond)
Heuser-Loy C.
europepmc   +1 more source

Association of CD19⁺-targeted chimeric antigen receptor (CAR) T-cell therapy with hypogammaglobulinemia, infection, and mortality. [PDF]

J Allergy Clin Immunol
Sutherland NM, Zhou B, Zhang L, Ong MS, Hong JS, Pak A, Liu KJ, Frigault MJ, Maus MV, Hill JA, Reynolds K, Walter JE, Camargo CA, Barmettler S.   +13 more
europepmc   +1 more source

Chimeric Antigen Receptor (CAR) T-cell Therapy in the Treatment of Diffuse Large B-cell Lymphoma (DLBCL): A Systematic Review. [PDF]

Cureus
Ibrahiam AT, Geddada S, Ullah N, Al-Qassab ZM, Ahmed O, Khan S.   +5 more
europepmc   +1 more source

CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Systemic Autoimmune Diseases. [PDF]

Cureus
Cingireddy AR, Flores B, Wuthrich J, Cingireddy AR.   +3 more
europepmc   +1 more source

Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin's Lymphoma. [PDF]

Pathog Immun
Giraudo MF, Jackson Z, Das I, Abiona OM, Wald DN.   +4 more
europepmc   +1 more source

Chimeric antigen receptor (CAR)-T-cell therapy for glioblastoma: what can we learn from the early clinical trials? A systematic review. [PDF]

Neurooncol Adv
Chan JTN, Henley-Waters J, Kayhanian S.
europepmc   +1 more source